New batch of COVID-19 vaccines part of clinical trials

The new batch of COVID-19 vaccines will also form part of a clinical trial.

On Saturday, 70,000 Johnson & Johnson doses arrived in the country.

So far, over 182,000 health workers have received the jab.

However, there are concerns that government will not reach its target of inoculating at least a million people by mid-April.

“As soon as the vaccines are available, I’m sure the pace of delivering the vaccines will be much faster,” said Jeffrey Mphahlele of the South African Medical Research Council.

“But clearly, the schedule is running behind and we can only hope that more vaccines will be available soon.”

Meanwhile, National Health Care Professionals Association Chairperson, Donald Gumede, said South Africa is unlikely to reach its 2021 coronavirus herd immunity target.

“Look at the bigger picture. We are 60 million people in the country and then you have inoculated — give or take 200,000 — we are far from reaching what we call herd immunity,” he said.

-eNCA

In other news – #BussItChallenge: Who did it better, Nadia Nakai VS Bontle Modiselle – Video

The Buss It Challenge has for the past few weeks dominated the social media streets. There is not a social media platform that you can go on that does not have the challenge as a trending topic. The challenge might have started oversees.

But how can a challenge that celebrates the fullness of a woman’s body not be owned by Africans- specifically South Africans that gave what was essentially a dying challenge new life. Learn More

The post New batch of COVID-19 vaccines part of clinical trials appeared first on News365.co.za.